HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Significant role of the choroidal outer layer during recovery from choroidal thickening in Vogt-Koyanagi-Harada disease patients treated with systemic corticosteroids.

AbstractBACKGROUND:
Which of the choroidal layers suffers the most extensive morphological changes during the course of Vogt-Koyanagi-Harada (VKH) disease is still unknown. The aim of this study was to investigate the relationship between total thickness and the thickness of inner or outer layers in the choroid during systemic corticosteroid therapy in patients with VKH disease.
METHODS:
This retrospective case series included 15 eyes of 10 patients with treatment-naïve VKH disease (4 men and 6 women; mean age, 41.4 ± 14.7 years) received systemic corticosteroid therapy. Whole, inner, and outer choroidal thickness was measured manually at 1 week and at 1 and 3 months after initiation of systemic corticosteroid therapy using enhanced depth imaging optical coherence tomography. The mean thickness values of the layers were compared at each stage.
RESULTS:
Compared with the 1-week baseline, the mean whole and outer choroidal layer thicknesses were significantly lower at 1 (P = 0.008 and 0.03, respectively) and 3 months (P = 0.008 and 0.02, respectively), whereas the inner layer did not significantly thin. Importantly, there was a significant positive correlation between the rates of change of whole and outer layer thickness from 1 week to 3 months (R = 0.9312, P < 0.0001), but not between the rates of whole and inner layer thickness changes.
CONCLUSIONS:
The thinning of total choroidal thickness observed after treatment with corticosteroids strongly correlated with outer layer thinning, suggesting that the choroidal outer layer is the primary target in acute-stage VKH disease.
AuthorsKiriko Hirooka, Wataru Saito, Kenichi Namba, Kazuomi Mizuuchi, Daiju Iwata, Yuki Hashimoto, Susumu Ishida
JournalBMC ophthalmology (BMC Ophthalmol) Vol. 15 Pg. 181 (Dec 18 2015) ISSN: 1471-2415 [Electronic] England
PMID26677974 (Publication Type: Journal Article)
Chemical References
  • Glucocorticoids
  • Prednisolone
  • Methylprednisolone
Topics
  • Adolescent
  • Adult
  • Choroid (pathology)
  • Choroid Diseases (drug therapy, physiopathology)
  • Female
  • Fluorescein Angiography
  • Glucocorticoids (therapeutic use)
  • Humans
  • Male
  • Methylprednisolone (therapeutic use)
  • Middle Aged
  • Prednisolone (therapeutic use)
  • Recovery of Function (physiology)
  • Retrospective Studies
  • Tomography, Optical Coherence
  • Uveomeningoencephalitic Syndrome (drug therapy, physiopathology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: